Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays

This publication has 22 references indexed in Scilit:

• Differential Eµ enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B‐cell populations, B‐cell non‐Hodgkin lymphomas, and Hodgkin lymphomas
  The Journal of Pathology, 2003
• The B-Cell Transcription Factors BSAP, Oct-2, and BOB.1 and the Pan–B-Cell Markers CD20, CD22, and CD79a Are Useful in the Differential Diagnosis of Classic Hodgkin Lymphoma
  American Journal of Clinical Pathology, 2003
• Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases
  Laboratory Investigation, 2003
• The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded Sections
  The American Journal of Surgical Pathology, 2002
• Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma
  Oncogene, 2002
• Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas
  Laboratory Investigation, 2002
• The Transcription Factor PU.1, Necessary for B-Cell Development Is Expressed in Lymphocyte Predominance, But Not Classical Hodgkin’s Disease
  The American Journal of Pathology, 2001
• Regulation of B Lymphocyte and Macrophage Development by Graded Expression of PU.1
  Science, 2000
• Cellular Origin of Human B-Cell Lymphomas
  New England Journal of Medicine, 1999
• Requirement of Transcription Factor PU.1 in the Development of Multiple Hematopoietic Lineages
  Science, 1994